• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of epigenetic mechanisms of nuclear receptor expression in prostatic carcinogenesis

Research Project

Project/Area Number 13670170
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Human pathology
Research InstitutionMie University

Principal Investigator

WATANABE Masatoshi  Mie University, Faculty of Medicine, Associate Prof., 医学部, 助教授 (90273383)

Co-Investigator(Kenkyū-buntansha) SHIRAISHI Taizo  Mie University, Faculty of Medicine, Prof., 医学部, 教授 (30162762)
Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥2,800,000 (Direct Cost: ¥2,800,000)
Fiscal Year 2002: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2001: ¥1,500,000 (Direct Cost: ¥1,500,000)
Keywordsprostate cancer / epigenetics / nuclear receptor / methylation / acetylation
Research Abstract

Epigenetic mechanisms including DNA methylation and histone deacetylation are thought to play important roles in gene transcriptional inactivation. We have reported the importance of that epigenetic regulations including CpG methylation and histone acetylation in the regulation of the AR. In addition, these results suggested involvement of methylation in expression of nuclear receptors. The retinoic acid receptor (RAR) β gene is a putative tumor suppressor gene on chromosome 3p24, where a high incidence of loss of heterozygosity is detected in many types of tumors. Selective loss or down-regulation of RARβ mRNA and protein has been reported in prostate cancers (PCas), although the mechanisms remain unclear. We investigated the role of epigenetic modification in RARβ2 gene silencing. Aberrant methylation was detected in 11 of 14 (79%) primary PCas, 9 of 10 (90%) hormone-refractory PCas, and 2 of 4 (50%) PCa cell lines, but not in any normal prostate samples. Chromatin immunoprecipitation assay showed that all RARβ2-negative cells (LNCaP, PC3, and DU145) were hypoacetylated at both histones H3 and H4. After exposure to 5-aza-2'-deoxycytidine treatment, Trichostatin A and all-trans retinoic acid induced partial demethylation, increased accumulation of acetylated histones, and markedly restored the expression of RARβ2 in RARβ2-negative cells. These results suggest that the RARβ2 gene may be one of the frequently silenced genes by epigenetic modifications in PCa. In addition, we found that methylation of the CD44 was related with prostate cancer progression. Our data shows that epigenetic mechanisms may be involved in expression of cancer-related genes.

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • Research Products

    (22 results)

All Other

All Publications (22 results)

  • [Publications] H.Takahashi et al.: "Mutation analysis of the p51 gene and correlation between p53, p73, and p51 expression in prostatic carcinoma"Prostate. 47. 85-90 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] T.Nakayama et al.: "The role of epigenetic modifications in retinoic acid receptor β2 gene expression in human prostate cancers"Lab Invest. 81. 1049-1057 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] N.Sekita et al.: "Methylation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines"Jpn J Cancer Res. 92. 947-951 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] H.Kitoh et al.: "Hypermethylation of the CD44 gene is associated with progression and metastasis of human prostate cancer"Prostate. 49. 110-115 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] M.Watanabe et al.: "Malignant phyllodes tumor of the prostate : Retrospective review of specimens obtained by sequential transurethral resection"Pathol Int. 52. 777-783 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 渡辺 昌俊他: "前立腺癌におけるエピジェネティックな遺伝子発現制御機構の解析"遺伝子医学. 5. 68-74 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] H.Takahashi, K.Fukutome, M.Watanabe, M.Furusato, T.Shiraishi, H.Ito, H.Suzuki, S.Ikawa, H.Hano: "Mutation analysis of the p51 gene and correlation between p53, p73, and p51 expression in prostatic carcinoma"Prostate. 47(2). 85-90 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] T.Onishi, K.Yamakawa, O.E.Franco, J.Kawamura, M.Watanabe, T.Shiraishi, S.Kitazawa: "Mitogen-activated protein kinase pathway is involved in α6 integrin gene expression in androgen-independent prostate cancer cells : role of proximal Sp1 consensus sequence"Biochim Biophys Acta. 1538(2-3). 218-227 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] T.Nakayama, M.Watanabe, M.Yamanaka, H.Suzuki, H.Ito, R.Yatani, T.Shiraishi: "The role of epigenetic modifications in retinoic acid receptor β2 gene expression in human prostate cancers"Lab Invest. 81(7). 1049-1057 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] N.Sekita, H.Suzuki, T.Ichikawa, H.Kito, K.Akakura, T.Igarashi, H.Ito, T.Nakayama, M.Watanabe, T.Shiraishi, M.Toyota, O.Yoshie: "Methylation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines"Jpn J Cancer Res. 92(9). 947-951 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] H.Kitoh, H.Suzuki, T.Ichikawa, N.Sekita, N.Kamiya, K.Akakura, T.Igarashi, T.Nakayama, M.Watanabe, K.Harigaya, H.Ito: "Hypermethylation of the CD44 gene is associated with progression and metastasis of human prostate cancer"Prostate. 49(2). 110-115 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] H.Suzuki, K.Akakura, A.Komiya, T.Ueda, Y.Furuya, T.Ichikawa, M.Watanabe, T.Shiraishi, H.Ito: "CAG polymorphic repeat lengths in androgen receptor gene among Japanese prostate cancer patients : Potential predictor of prognosis after endocrine therapy"Prostate. 51(3). 219-224 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] M.Watanabe, Y.Yamada, H.Kato, H.Imai, H.Nakano, T.Araki, and T.Shiraishi: "Malignant phyllodes tumor of the prostate : Retrospective review of specimens obtained by sequential transurethral resection"Pathology Int.. 52. 777-783 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] H.Takahashi, et al.: "Mutation analysis of the p51 gene and correlation between p53, p73, and p51 expression in prostatic carcinoma"Prostate. 47・2. 85-90 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] T.Nakayama et al.: "The role of epigenetic modifications in retinoic acid receptor β2 gene expression in human prostate cancers"Lab Invest. 81・7. 1049-1057 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] N.Sekita, et al.: "Methylation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines"Jpn J Cancer Res. 92・9. 947-951 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] H.Kitoh, et al.: "Hypermethylation of the CD44 gene is associated with progression and metastasis of human prostate cancer"Prostate. 49・2. 110-115 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] M.Watanabe, et al.: "Malignant phyllodes tumor of the prostate : Retrospectiie review of specimens obcained by sequentiol transmethral resection"Pathology Int. 52・12. 777-783 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 渡辺昌俊 他: "前立腺癌におけるエピジュネティックな遺伝子発現制御機構の解析"遺伝子 医学. 5・4. 68-74 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] T.Nakayama, M.Watanabe, et al.: "The Role of Epigenetic Medificationsin Retinoic Acid Recept β_2 Gene Expression in Human Prostate Cancers"Lab.Invest.. 81. 1049-1057 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] N.Sekita, M.Watanabe, et al.: "Methylation of the KAI1 Metastosis Suppressor Gene in Human Prostate Cancer Cell Lines"Jpn.J.Cancer Res.. 92. 947-951 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] H.Kitoh, M.Watanabe, et.al.: "Hypermethylation of CD44 gene is associated with prognosis and metastasis of human prostate cancer"Prostate. 49. 110-115 (2001)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi